ArticleEuropean heart journal. Cardiovascular pharmacotherapy2025
Correction to: The dual endothelin-1 antagonist aprocitentan alleviates mitochondrial oxidative stress in human cardiac fibroblasts.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.